Igc reports financial results for september 30, 2020 quarter and start of phase 1 cannabinoid clinical trial for alzheimer's patients

Potomac, md.--(business wire)-- #ad--india globalization capital, inc. (“igc” or the “company”) (nyse american: igc) today announced its financial results for the quarter ended september 30, 2020, which is the second quarter of its 2021 fiscal year, and the start of phase 1 cannabinoid-based clinical trial for alzheimer's patients. revenue in the quarter ended september 30, 2020 and september 30, 2019, were $125 thousand and $1,821 thousand, respectively. the decrease in revenue is primarily due to r
IGC Ratings Summary
IGC Quant Ranking